Cellular basis of long-term organ transplant acceptance: pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance
- PMID: 9469488
- DOI: 10.1053/ajkd.1998.v31.pm9469488
Cellular basis of long-term organ transplant acceptance: pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance
Abstract
Long-term acceptance of MHC-incompatible organ allografts without chronic immunosuppressive therapy has been achieved in experimental animals. There are also reports, mainly in liver transplant, of patients who after complete withdrawal of immunosuppressants still have a functioning graft. It has been proposed that organ transplant implies a migratory flux of donor "passenger" leukocytes out of the graft into the recipient tissues or organs, serving to establish a persistent condition of "microchimerism," and being a tolerogenic precursor of chimeric cells. Although there is evidence that the same migratory mechanisms apply to all organ grafts, migration of passenger leukocytes is less in organs other than the liver, such as the kidney and heart. To enhance the acceptance of organs less tolerogenic than the liver, perioperative infusion of donor bone marrow has been attempted to increase the migration of donor leukocytes of bone marrow origin. It has been suggested that such peripheral donor microchimerism is not only associated with long-term acceptance of the organ graft but that it plays an active role in induction and maintenance of unresponsiveness. However, the intimate mechanisms(s) responsible for prolonged organ survival in this setting remains speculative. Experimental evidence that the thymus plays the major role in the development of self-tolerance and is also critical in the induction of acquired tolerance to exogenous antigens has focussed the attention on the intrathymic events that lead to donor-specific unresponsiveness to allograft. Data are available showing that after direct intrathymic injection of donor cells, clonal deletion of maturing host thymocytes occurs and is the major mechanism in the induction of donor-specific tolerance. The central role of the thymus in transplant tolerance is also supported by more recent findings that in mixed allogeneic bone marrow chimeras in mice with a nonmyeloablative conditioning regimen, migration of donor bone marrow-derived dendritic cells to the thymus serves to negatively select newly developing host T cells. Therefore, the peripheral T-cell component would be devoid of alloreactive population. Thus, lifelong intrathymic clonal deletion is the only significant mechanism involved in the maintenance of donor-specific T-cell tolerance that would allow the subsequent vascularized organ from the same donor to survive indefinitely.
Similar articles
-
Acquired transplant tolerance.Int J Clin Lab Res. 1997;27(3):165-77. doi: 10.1007/BF02912453. Int J Clin Lab Res. 1997. PMID: 9352379 Review.
-
Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.Biol Blood Marrow Transplant. 2001;7(12):646-55. doi: 10.1053/bbmt.2001.v7.pm11787527. Biol Blood Marrow Transplant. 2001. PMID: 11787527
-
Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.J Immunol. 1994 Aug 1;153(3):1087-98. J Immunol. 1994. PMID: 8027542
-
Donor-specific tolerance in a murine model: the result of extra-thymic T cell deletion?Transpl Immunol. 2003 Jul-Sep;11(3-4):375-84. doi: 10.1016/S0966-3274(02)00157-0. Transpl Immunol. 2003. PMID: 12967790
-
Transplantation tolerance and mixed chimerism: at the frontier of clinical application.Transpl Int. 2001;14(1):1-5. Transpl Int. 2001. PMID: 11263549 Review.
Cited by
-
Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?Int J Hematol. 2002 Aug;76 Suppl 1:226-47. doi: 10.1007/BF03165251. Int J Hematol. 2002. PMID: 12430858 Review.
-
Human muscle in gene edited pigs for treatment of volumetric muscle loss.Front Genet. 2022 Jul 25;13:948496. doi: 10.3389/fgene.2022.948496. eCollection 2022. Front Genet. 2022. PMID: 35957684 Free PMC article. Review.
-
Thymic re-entry of mature activated T cells and increased negative selection in vascularized allograft recipients.Clin Exp Immunol. 2002 Jan;127(1):43-52. doi: 10.1046/j.1365-2249.2002.01717.x. Clin Exp Immunol. 2002. PMID: 11882031 Free PMC article.
-
Human pancreatic islet-derived progenitor cell engraftment in immunocompetent mice.Am J Pathol. 2004 Mar;164(3):817-30. doi: 10.1016/S0002-9440(10)63170-7. Am J Pathol. 2004. PMID: 14982836 Free PMC article.
-
Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.Drugs. 2008;68(15):2113-30. doi: 10.2165/00003495-200868150-00004. Drugs. 2008. PMID: 18840003 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials